Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
1
BCHMY Quote, Financials, Valuation and Earnings
Last price:
$6.47
Seasonality move
:
-32.88%
Day range:
$6.45 - $6.47
52-week range:
$5.94 - $10.18
Dividend yield:
1.35%
P/E ratio:
38.15x
P/S ratio:
7.52x
P/B ratio:
3.34x
Volume:
359
Avg. volume:
3.3K
1-year change:
-26.89%
Market cap:
$4.9B
Revenue:
$642.9M
EPS (TTM):
$0.17
Analysts' Opinion
-
Consensus RatingBachem Holding AG has received a consensus rating of Buy. The company's average rating is a Buy based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of --, Bachem Holding AG has an estimated downside of -- from its current price of $6.47.
-
Price Target UpsideAccording to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $6.47.
Fair Value
-
According to the consensus of 0 analysts, Bachem Holding AG has -- downside to fair value with a price target of -- per share.
BCHMY vs. S&P 500
-
Over the past 5 trading days, Bachem Holding AG has underperformed the S&P 500 by -8.32% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Bachem Holding AG does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Bachem Holding AG has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Bachem Holding AG reported revenues of --.
Earnings Growth
-
Bachem Holding AG has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Bachem Holding AG reported earnings per share of --.
Enterprise value:
4.7B
EV / Invested capital:
--
Price / LTM sales:
7.52x
EV / EBIT:
32.49x
EV / Revenue:
7.21x
PEG ratio (5yr expected):
2.00x
EV / Free cash flow:
-79.67x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
23.69x
Gross Profit (TTM):
$201M
Return On Assets:
6.84%
Net Income Margin (TTM):
19.7%
Return On Equity:
8.65%
Return On Invested Capital:
8.65%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-23 | 2023-12-23 | 2023-12-23 | |||
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -- | -- | -- | -- | -- | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $353.5M | $400.1M | $757.9M | $867.6M | $831.6M | |
| Total Assets | $697.9M | $834.9M | $1.3B | $1.7B | $1.9B | |
| Current Liabilities | $137M | $261.6M | $106.9M | $222.9M | $243.5M | |
| Total Liabilities | $238.6M | $305.3M | $156.3M | $278.9M | $461.7M | |
| Total Equity | $459.4M | $529.6M | $1.2B | $1.4B | $1.5B | |
| Total Debt | $63.3M | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-23 | 2023-12-23 | 2023-12-23 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
BCHMY
Sector
Market Cap
$4.9B
$44.6M
Price % of 52-Week High
63.56%
45.71%
Dividend Yield
1.35%
0%
Shareholder Yield
--
-0.68%
1-Year Price Total Return
-26.89%
-29.09%
Beta (5-Year)
--
0.772
Dividend yield:
1.35%
Annualized payout:
$0.00
Payout ratio:
52.1%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$7.17
200-day SMA
Sell
Level
$8.67
Bollinger Bands (100)
Sell
Level
7.67 - 9.25
Chaikin Money Flow
Sell
Level
-1.6K
20-day SMA
Sell
Level
$7.37
Relative Strength Index (RSI14)
Sell
Level
34.72
ADX Line
Sell
Level
13.78
Williams %R
Buy
Level
-98.7013
50-day SMA
Sell
Level
$7.89
MACD (12, 26)
Sell
Level
-0.29
25-day Aroon Oscillator
Sell
Level
-80
On Balance Volume
Sell
Level
-4.1K
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (9.444)
Buy
CA Score
(Annual)
Level (1.4613)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-2.9354)
Buy
Piotroski F Score
(Annual)
Level (6)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Bachem Holding AG is a biochemical company that provides services to the pharmaceutical and biotechnology industry. It focuses on specializing in the development and manufacture of peptides and oligonucleotides. The group markets its products under the Bachem and Clinalfa brands. It has two geographic segments Europe/Asia and North America. Its products and services are CMC Development, Commercial API, Research and Specialities, and Services and Capabilities.
Stock Forecast FAQ
In the current month, BCHMY has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The BCHMY average analyst price target in the past 3 months is --.
-
Where Will Bachem Holding AG Stock Be In 1 Year?
According to analysts, the consensus estimate is that Bachem Holding AG share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Bachem Holding AG?
Analysts are divided on their view about Bachem Holding AG share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Bachem Holding AG is a Sell and believe this share price will rise from its current level to --.
-
What Is Bachem Holding AG's Price Target?
The price target for Bachem Holding AG over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is BCHMY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Bachem Holding AG is a Buy. 0 of 0 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of BCHMY?
You can purchase shares of Bachem Holding AG via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Bachem Holding AG shares.
-
What Is The Bachem Holding AG Share Price Today?
Bachem Holding AG was last trading at $6.47 per share. This represents the most recent stock quote for Bachem Holding AG. Yesterday, Bachem Holding AG closed at $6.47 per share.
-
How To Buy Bachem Holding AG Stock Online?
In order to purchase Bachem Holding AG stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
